Carlotta Welters
Research Subjects
Carlotta Welters has a total of 50 co-authors. Here are the top co-authors by number of shared publications:
- Leo Hansmann
Department of Internal Medicine III, University Hospital Regensburg, Regensburg, Germany
32 shared publications - Amin Ben-Hamza
Department of Hematology, Oncology, and Tumor Immunology, Charit e-Universit€ atsmedizin Berlin, Corporate Member of Freie Universit€ at Berlin and
30 shared publications - Serena Stadler
Department of Pediatric Hematology and Oncology, Justus-Liebig University, Giessen, Germany
23 shared publications - Christine Damm-Welk
Department of Pediatric Hematology and Oncology, Justus-Liebig University, Giessen, Germany
22 shared publications - Rafael B. Blasco
Department of Pathology, Boston Children’s Hospital and Harvard Medical School, Boston, Massachusetts
22 shared publications - Roberto Chiarle
Department of Molecular Biotechnology and Health Sciences, University of Torino, Torino, Italy
22 shared publications
Latest Publications
- Open Access
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Supplementary Figure S2 from Endogenous CD4+ T Cells That Recognize ALK and the NPM1::ALK Fusion Protein Can Be Expanded from Human Peripheral Blood
Supplementary Figure S2: Gating strategy for single cell sorting of patient 04 CD4+TCRab+ T cells.
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Figure S2 from Endogenous CD4+ T Cells That Recognize ALK and the NPM1::ALK Fusion Protein Can Be Expanded from Human Peripheral Blood
Supplementary Figure S2: Gating strategy for single cell sorting of patient 04 CD4+TCRab+ T cells.
- Open Access
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Supplementary Table S1 from Endogenous CD4+ T Cells That Recognize ALK and the NPM1::ALK Fusion Protein Can Be Expanded from Human Peripheral Blood
Supplementary Table 1: Characteristics of ALK+ALCL patients in this study
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Table S1 from Endogenous CD4+ T Cells That Recognize ALK and the NPM1::ALK Fusion Protein Can Be Expanded from Human Peripheral Blood
Supplementary Table 1: Characteristics of ALK+ALCL patients in this study
- Open Access
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Supplementary Table S5 from Endogenous CD4+ T Cells That Recognize ALK and the NPM1::ALK Fusion Protein Can Be Expanded from Human Peripheral Blood
Supplementary Table 5: List of selected TCRs identified by single cell TCRab sequencing.
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Table S5 from Endogenous CD4+ T Cells That Recognize ALK and the NPM1::ALK Fusion Protein Can Be Expanded from Human Peripheral Blood
Supplementary Table 5: List of selected TCRs identified by single cell TCRab sequencing.
- Open Access
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Supplementary Table S6 from Endogenous CD4+ T Cells That Recognize ALK and the NPM1::ALK Fusion Protein Can Be Expanded from Human Peripheral Blood
Supplementary Table 6: Binding prediction of the NPM1::ALK fusion peptide to HLADRB13 alleles.
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Table S6 from Endogenous CD4+ T Cells That Recognize ALK and the NPM1::ALK Fusion Protein Can Be Expanded from Human Peripheral Blood
Supplementary Table 6: Binding prediction of the NPM1::ALK fusion peptide to HLADRB13 alleles.
- Open Access
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Supplementary Table S4 from Endogenous CD4+ T Cells That Recognize ALK and the NPM1::ALK Fusion Protein Can Be Expanded from Human Peripheral Blood
Supplementary Table 4: Summary of the CD4 T cell responses to ALK in healthy donors
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Table S4 from Endogenous CD4+ T Cells That Recognize ALK and the NPM1::ALK Fusion Protein Can Be Expanded from Human Peripheral Blood
Supplementary Table 4: Summary of the CD4 T cell responses to ALK in healthy donors
- Open Access
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Supplementary Figure S1 from Endogenous CD4+ T Cells That Recognize ALK and the NPM1::ALK Fusion Protein Can Be Expanded from Human Peripheral Blood
Supplementary Figure S1: ALK-reactive CD4 T cells of patient 04 at diagnosis
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Figure S1 from Endogenous CD4+ T Cells That Recognize ALK and the NPM1::ALK Fusion Protein Can Be Expanded from Human Peripheral Blood
Supplementary Figure S1: ALK-reactive CD4 T cells of patient 04 at diagnosis
- Open Access
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Supplementary Data File S1 from Endogenous CD4+ T Cells That Recognize ALK and the NPM1::ALK Fusion Protein Can Be Expanded from Human Peripheral Blood
Supplementary Data File S1 from Endogenous CD4+ T Cells That Recognize ALK and the NPM1::ALK Fusion Protein Can Be Expanded from Human Peripheral Blood
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Data File S1 from Endogenous CD4+ T Cells That Recognize ALK and the NPM1::ALK Fusion Protein Can Be Expanded from Human Peripheral Blood
Supplementary Data File S1 from Endogenous CD4+ T Cells That Recognize ALK and the NPM1::ALK Fusion Protein Can Be Expanded from Human Peripheral Blood
- Open Access
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Supplementary Table S3 from Endogenous CD4+ T Cells That Recognize ALK and the NPM1::ALK Fusion Protein Can Be Expanded from Human Peripheral Blood
Supplementary Table 3: Summary of the CD4 T cell responses to ALK in ALCL patients
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Table S3 from Endogenous CD4+ T Cells That Recognize ALK and the NPM1::ALK Fusion Protein Can Be Expanded from Human Peripheral Blood
Supplementary Table 3: Summary of the CD4 T cell responses to ALK in ALCL patients
- Open Access
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Supplementary Table S2 from Endogenous CD4+ T Cells That Recognize ALK and the NPM1::ALK Fusion Protein Can Be Expanded from Human Peripheral Blood
Supplementary Table 2: List of NPM1::ALK peptide sequences and ALK pools
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Table S2 from Endogenous CD4+ T Cells That Recognize ALK and the NPM1::ALK Fusion Protein Can Be Expanded from Human Peripheral Blood
Supplementary Table 2: List of NPM1::ALK peptide sequences and ALK pools
- Open Access
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Supplementary Figure S3 from Endogenous CD4+ T Cells That Recognize ALK and the NPM1::ALK Fusion Protein Can Be Expanded from Human Peripheral Blood
Supplementary Figure S3: Gating strategy for identification of GFP-positive 58-TCR transgenic cells in co-cultures.
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Figure S3 from Endogenous CD4+ T Cells That Recognize ALK and the NPM1::ALK Fusion Protein Can Be Expanded from Human Peripheral Blood
Supplementary Figure S3: Gating strategy for identification of GFP-positive 58-TCR transgenic cells in co-cultures.